Clinical safety and activity of AG-120, a first-in-class, potent inhibitor of the IDH1 mutant protein, in a phase 1 study of patients with advanced IDH1-mutant hematologic malignancies Meeting Abstract
| Authors: | de Botton, S.; Pollyea, D. A.; Stein, E. M.; DiNardo, C.; Fathi, A. T.; Roboz, G. J.; Collins, R.; Swords, R. T.; Flinn, I.; Altman, J. K.; Tallman, M. S.; Kantarjian, H.; Colby, K.; Fan, B.; Goldwasser, M.; Prahl, M.; Agresta, S.; Stone, R. M. |
| Abstract Title: | Clinical safety and activity of AG-120, a first-in-class, potent inhibitor of the IDH1 mutant protein, in a phase 1 study of patients with advanced IDH1-mutant hematologic malignancies |
| Meeting Title: | 20th Congress of the European Hematology Association (EHA) |
| Journal Title: | Haematologica |
| Volume: | 100 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2015 Jun 11-14 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2015-06-01 |
| Start Page: | 214 |
| End Page: | 215 |
| Language: | English |
| ACCESSION: | WOS:000361204902068 |
| PROVIDER: | wos |
| PMCID: | PMC4480587 |
| Notes: | Meeting Abstract: P563 -- Source: Wos |
